Thursday Jun 19, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home In Brief

Report: Teva settles investor lawsuit for $420M

by  ILH Staff
Published on  01-23-2022 11:51
Last modified: 01-23-2022 11:51
Report: Teva settles investor lawsuit for $420MSivan Faraj

Teva's offices in Kfar Saba, central Israel | File photo: Sivan Faraj

Share on FacebookShare on Twitter

Teva Pharmaceutical Industries has settled a class action filed against it by investors in the US over the price-fixing affair in which the company was allegedly involved.

Follow Israel Hayom on Facebook, Twitter, and Instagram

According to financial daily Globes, Teva will pay $420 million, without admitting wrongdoing, and it denies the claims.

Shareholders sued Teva in 2016 following an investigation by the US authorities into alleged price-fixing in the generic drugs industry. In 2020, the US Department of Justice alleged that Teva's price-fixing cost US consumers over $350 million. Other generics companies, including Israeli company Taro, reached settlements in the affair, but Teva did not, the report said.

In a statement, Teva said, "We continue to settle complex legal cases in order to be able to focus on our mission of providing access to life-saving drugs at affordable prices all over the world. Teva's insurers will bear most of the amount of the settlement, alongside a small sum to be paid by Teva. In addition, Teva does not admit any responsibility and denies the claims. Settlement of the matter reflects the general interest of Teva, and of the patients who continue to rely on us daily for the largest generic drugs portfolio in the world."

Related Posts

In first, police inaugurates bulletproof ambulances

In first, police inaugurates bulletproof ambulances

by Itsik Saban

"We have only recently finished debriefing the events of Oct. 7," Israel Police Commissioner Yaakov Shabtai says. "There were officers...

Israel to hold 7th annual national waste conferenceHiriya Recycling Park

Israel to hold 7th annual national waste conference

by ILH Staff

  The 7th Annual Waste Management Conference, set for Tuesday, comes as Israel faces a critical juncture in waste management....

Rare archival photos unveiled in honor of Jerusalem DayLazer Doner, KKL-JNF Archive

Rare archival photos unveiled in honor of Jerusalem Day

by ILH Staff

  In celebration of Jerusalem Day, Keren Kayemeth LeIsrael-Jewish National Fund has unveiled rare archival photos, offering a glimpse into...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il